Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1601–1650 of 18397
On April 10, 2025, Kathleen Simpson-Taylor notified A-Mark Precious Metals, Inc. (“A-Mark” or the “Company”) of her intention to resign as Chief Financial Officer, Executive Vice President and Assistant Secretary, effective June 30, 2025.
On April 14, 2025, the board of directors of Vince Holding Corp. (the “Company”) appointed Yuji Okumura, age 41, the Company’s current Interim Chief Financial Officer, to serve as the Company’s Chief Financial Officer on a permanent basis effective immediately.
the Board promoted Matthew F. Wajner to the position of Chief Financial Officer, effective as of April 10, 2025.
the Board promoted Mark E. Seaton to the position of Chief Executive Officer and appointed him as a director of the Company, effective as of April 10, 2025.
Kenneth D. DeGiorgio ceased to serve as Chief Executive Officer and a member of the Board of Directors of the Company (the “Board”), effective as of April 10, 2025.
Adam A. Chamberlain will transition from his current role as Executive Vice President, Chief Operating Officer at Lithia Motors, Inc. (the “Company”) to assume the role of CEO of Mercedes-Benz USA, and therefore is resigning from his position with the Company, effective June 1, 2025.
On April 15, 2025, Caterpillar Inc. (the “Company”) announced that, on April 9, 2025, the Board of Directors (the “Board”) of the Company appointed Joseph E. Creed (49) as the Company’s Chief Executive Officer and as a member of the Board, effective May 1, 2025, succeeding D. James Umpleby III.
Mr. Onorati succeeds Blake Janover, who previously served as Chief Executive Officer.
effective April 4, 2025, Joseph Onorati was appointed as the Chief Executive Officer of Janover Inc.
On April 9, 2025, Michael A. Bender informed the board of directors (the “Board”) of Pacific Oak Strategic Opportunity REIT, Inc. (the “Company”) of his resignation from his position as Executive Vice President, Chief Financial Officer, Treasurer and Secretary of the Company effective as of April 17, 2025.
Ken Myszkowski notified Arrowhead Pharmaceuticals, Inc. (the “Company”) of his decision to retire as Chief Financial Officer of the Company, effective as of May 13, 2025
the Company determined that it would appoint Daniel Apel to serve as Chief Financial Officer of the Company
Renger van den Heuvel was appointed as the Chief Executive Officer of the Company and as a member of the Company’s Board of Directors.
Also on April 14, 2025, the Company appointed Daniel J. Rice IV, the Company’s Chief Executive Officer, as President and Interim Chief Financial Officer and Marc Horstman as Chief Operating Officer.
On April 14, 2025, it was determined that Brian Allen and Akash Patel will no longer serve as President and Chief Operating Officer and Chief Financial Officer, respectively, of Net Power Inc. (the “Company”), effective as of April 15, 2025.
on April 15, 2025, the board of directors of the Company appointed Ellen Conti to serve as the Company’s Chief Financial Officer and Treasurer and as a member of its board of directors.
On April 11, 2025, Herbert Alvin (“Hap”) Pollard notified the Company of his resignation as Chief Financial Officer and Treasurer and as a member of the board of directors of Sculptor Diversified Real Estate Income Trust, Inc.
Craig W. Best, President of the Corporation and Farmers and Merchants Trust Company of Chambersburg (the “Bank”), will succeed Timothy G. Henry as Chief Executive Officer of the Corporation and the Bank on April 29, 2025 upon conclusion of the Corporation’s 2025 Annual Meeting.
Mr. Henry’s previously announced retirement date of April 29, 2025 has been extended to May 2, 2025.
On April 12, 2025, Gavin D.K. Hattersley, President and Chief Executive Officer of Molson Coors Beverage Company (the “Company”) and a member of the Company’s Board of Directors (the “Board”), informed the Company and the Board that he intends to retire from the Company and as a member of the Board, in each case, by December 31, 2025.
Effective April 14, 2025, the Board appointed David McIntyre as Chief Financial Officer, principal financial officer and principal accounting officer of the Company (the “Appointment”).
Effective April 11, 2025, Garth Lees-Rolfe resigned as Chief Financial Officer, principal financial officer and principal accounting officer of Inhibikase Therapeutics, Inc. (the “Company”).
Michael H. Jenkins, the Company’s Chief Executive Officer, has been replaced as Chief Executive Officer of the Company (the “Termination Date”).
the Company also announced its Board’s appointment of Sally A. Washlow as the Company’s new Chief Executive Officer, effective as of Mr. Jenkins’ Termination Date.
pursuant to which he will be appointed Executive Vice President and Chief Financial Officer of the Company, effective May 5, 2025.
Bryan Castellani will step down as Executive Vice President and CFO, effective May 5, 2025.
Mr. Jensen resigned as Chief Financial Officer
Mr. Chin resigned as Chief Executive Officer
On April 13, 2025, Michael Geary was appointed to serve as Interim Chief Financial Officer of ClimateRock, effective immediately.
the Board appointed Denise W. Warren, current Chairman of the Board, as Interim Chief Executive Officer, to serve until the appointment of a new Chief Executive Officer of the Company.
On April 14, 2025, the Company announced that the board of directors of the Company (the “Board”) and Lucinda M. Baier, the Company’s President and Chief Executive Officer and member of the Board, mutually agreed that Ms. Baier’s role serving as the Company’s President and Chief Executive Officer and as a member of the Board would cease, effective as of April 13, 2025.
Mr. Wood’s employment with Adaptimmune Limited will end on August 31, 2025 (the “Revised Termination Date”) by reason of redundancy.
On the same date, to fill the vacancy, the Board elected Sam Zheng Sun as a Director of the Company and Chairperson of the Board of Directors, as well as appointed Sam Zheng Sun as the Chief Executive Officer of the Company.
Effective April 14, 2025, Bian Fan was removed as Director, Chairperson of the Board of Directors and Chief Executive Officer of DT Cloud Star Acquisition Corporation (the “Company”) by the written consent of the board
On April 11, 2025, Richard Tarapchak was promoted and appointed as the Chief Financial Officer of the Company and its subsidiaries and was designated as the Company’s Principal Financial Officer.
On April 14, 2025, Verano Holdings Corp., a British Columbia corporation (the “ Company ”), announced that Brett Summerer resigned as Chief Financial Officer of the Company and from all officer and other positions with its subsidiaries.
appointed Ben C. Rodgers to the role of executive vice president and chief financial officer, effective as of May 12, 2025
At the same time the Board appointed Shrilakshmi Vadlapatla as CFO.
On April 11 th , 2025, James Cardwell resigned his position as CFO of the Corporation.
the executive officers of the Company are: • Andrew Milgram, Chief Executive Officer; • Paul Arrouet, President; and • Jeffrey Kravetz, Chief Financial Officer.
the executive officers of the Company are: • Andrew Milgram, Chief Executive Officer; • Paul Arrouet, President; and • Jeffrey Kravetz, Chief Financial Officer.
the Board of Directors (the “Board”) of the Company appointed Mr. David Ayanoglou to serve as the Company’s Chief Financial Officer, effective immediately.
On April 8, 2025, Mr. Thyagarajan Ramachandran informed the Company that they had decided to resign from their position as the Chief Financial Officer of the Company, effective April 10, 2025, along with the appointment of Mr. David Ayanoglou as the new Chief Financial Officer of the Company.
On February 26, 2025, RBB Bancorp (the “Company”) and its wholly-owned subsidiary, Royal Business Bank (the “Bank”), entered into an Agreement and Release of Claims (the “Retirement Agreement”) with Mr. David Morris, the Company’s Chief Executive Officer, confirming the terms of his retirement and voluntary termination of his employment following the next annual meeting of the Company’s shareholders, which is expected to be held May 21, 2025.
On April 11, 2025, Timothy Foufas resigned as Co-Chief Executive Officer of The LGL Group, Inc. ("LGL Group" or the "Company"), effective May 1, 2025.
On April 11, 2025, the Board of Directors of vTv Therapeutics Inc. (the “Company”) appointed Barry K. Brown, age 64, as interim principal financial officer effective immediately.
The Board of the Company appointed Ti Chieh Zang (age 36) as the Director, Chief Executive Officer and Chief Financial Officer, effective on April 9, 2025.
Tak Chun Wong, the Director, Chief Executive Officer and Chief Financial Officer of AFB Limited. (the "Company"), is no longer holding the positions.
appointed Sheryl A. Lisowski, the Company's Executive Vice President – Chief Accounting Officer and Treasurer, to serve in the additional role of interim Chief Financial Officer of the Company, effective April 17, 2025
On April 9, 2025, James A.J. Nickolas notified Martin Marietta of his decision to resign as Executive Vice President and Chief Financial Officer, effective April 11, 2025
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.